BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antidepressant boost brain tumor treatment?
Disease control OngoingThis study tests whether fluoxetine, an FDA-approved antidepressant, can make chemotherapy more effective for people with a recurrent type of brain tumor called IDHwt glioma. Ten participants will receive either fluoxetine or no additional drug before surgery, and researchers wil…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: EARLY_PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Engineered immune cells injected directly into brain tumors: a new hope?
Disease control OngoingThis early-phase study tests a new treatment for people with HER2-positive brain tumors that have come back or not responded to standard care. The treatment involves taking a patient's own immune cells (T cells), adding a special antibody (HER2-CAR) to help them recognize and att…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 13, 2026 15:59 UTC